ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985

Working Group Considering formal Cap On size of Cancer Center Support Grants

March 22, 1996

Caplan: NEJM Should Go “The Extra Moral Mile”

January 9, 2009

NCI advisors approve $50 million pilot for Human Cancer Genome Project; NHLBI Director Collins calls it a “unique, historic opportunity.”

November 18, 2005

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998